中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2015年
2期
106-109
,共4页
林辉%杨远%林川%潘泽亚%周伟平%吴孟超
林輝%楊遠%林川%潘澤亞%週偉平%吳孟超
림휘%양원%림천%반택아%주위평%오맹초
肝肿瘤%肝尾状叶%肝切除术
肝腫瘤%肝尾狀葉%肝切除術
간종류%간미상협%간절제술
Liver neoplasms%Hepatic caudate lobe%Hepatectomy
目的 探讨肝尾状叶良性肿瘤的手术疗效.方法 回顾性分析2003年1月至2014年4月第二军医大学附属东方肝胆外科医院收治的1 12例肝尾状叶良性肿瘤患者的临床资料.根据肿瘤部位、大小等选择采用左侧入路、右侧入路、双侧入路、中央前入路或逆行肝尾状叶切除术.采用门诊或电话方式进行随访,随访时间截至2014年10月.结果 112例患者均具有手术治疗的适应证,均完整切除肿瘤,其中行单纯肝尾状叶肿瘤切除术33例(22例双侧入路、11例左侧入路),左半肝+尾状叶切除术28例(左侧入路),肝中叶+尾状叶切除术21例(中央前入路),部分肝右叶+尾状叶切除术19例(右侧入路),右半肝+尾状叶切除术11例(9例右侧入路、2例逆行切除).术中单纯入肝血流阻断72例,入肝血流联合肝静脉阻断29例,全肝血流阻断6例,未行肝血流阻断5例.手术时间为(192±69) min,平均入肝血流阻断时间为28 min(0 ~94 min),平均术中出血量为590 mL(100~ 12 000 mL),术中输血例数为68例,平均输血量为600 mL(200 ~ 10 000 mL),术后住院时间为(8.2±2.7)d.31例患者术后发生并发症,其中胆汁漏21例,中等量以上胸腔积液7例,术后出血2例,均经对症处理后痊愈;肝衰竭1例,经保肝治疗后好转.无围术期死亡患者.112例患者均获得术后随访,中位随访时间为12个月(6~24个月).随访期间,112例患者均健康生存,无一例患者肿瘤复发或因手术相关并发症死亡.结论 手术切除是治疗肝尾状叶良性肿瘤的有效手段,患者术后恢复良好,手术疗效确切.严格把握手术适应证,合理优化手术路径,术中采用选择性肝血流阻断,精细操作是手术成功的关键.
目的 探討肝尾狀葉良性腫瘤的手術療效.方法 迴顧性分析2003年1月至2014年4月第二軍醫大學附屬東方肝膽外科醫院收治的1 12例肝尾狀葉良性腫瘤患者的臨床資料.根據腫瘤部位、大小等選擇採用左側入路、右側入路、雙側入路、中央前入路或逆行肝尾狀葉切除術.採用門診或電話方式進行隨訪,隨訪時間截至2014年10月.結果 112例患者均具有手術治療的適應證,均完整切除腫瘤,其中行單純肝尾狀葉腫瘤切除術33例(22例雙側入路、11例左側入路),左半肝+尾狀葉切除術28例(左側入路),肝中葉+尾狀葉切除術21例(中央前入路),部分肝右葉+尾狀葉切除術19例(右側入路),右半肝+尾狀葉切除術11例(9例右側入路、2例逆行切除).術中單純入肝血流阻斷72例,入肝血流聯閤肝靜脈阻斷29例,全肝血流阻斷6例,未行肝血流阻斷5例.手術時間為(192±69) min,平均入肝血流阻斷時間為28 min(0 ~94 min),平均術中齣血量為590 mL(100~ 12 000 mL),術中輸血例數為68例,平均輸血量為600 mL(200 ~ 10 000 mL),術後住院時間為(8.2±2.7)d.31例患者術後髮生併髮癥,其中膽汁漏21例,中等量以上胸腔積液7例,術後齣血2例,均經對癥處理後痊愈;肝衰竭1例,經保肝治療後好轉.無圍術期死亡患者.112例患者均穫得術後隨訪,中位隨訪時間為12箇月(6~24箇月).隨訪期間,112例患者均健康生存,無一例患者腫瘤複髮或因手術相關併髮癥死亡.結論 手術切除是治療肝尾狀葉良性腫瘤的有效手段,患者術後恢複良好,手術療效確切.嚴格把握手術適應證,閤理優化手術路徑,術中採用選擇性肝血流阻斷,精細操作是手術成功的關鍵.
목적 탐토간미상협량성종류적수술료효.방법 회고성분석2003년1월지2014년4월제이군의대학부속동방간담외과의원수치적1 12례간미상협량성종류환자적림상자료.근거종류부위、대소등선택채용좌측입로、우측입로、쌍측입로、중앙전입로혹역행간미상협절제술.채용문진혹전화방식진행수방,수방시간절지2014년10월.결과 112례환자균구유수술치료적괄응증,균완정절제종류,기중행단순간미상협종류절제술33례(22례쌍측입로、11례좌측입로),좌반간+미상협절제술28례(좌측입로),간중협+미상협절제술21례(중앙전입로),부분간우협+미상협절제술19례(우측입로),우반간+미상협절제술11례(9례우측입로、2례역행절제).술중단순입간혈류조단72례,입간혈류연합간정맥조단29례,전간혈류조단6례,미행간혈류조단5례.수술시간위(192±69) min,평균입간혈류조단시간위28 min(0 ~94 min),평균술중출혈량위590 mL(100~ 12 000 mL),술중수혈례수위68례,평균수혈량위600 mL(200 ~ 10 000 mL),술후주원시간위(8.2±2.7)d.31례환자술후발생병발증,기중담즙루21례,중등량이상흉강적액7례,술후출혈2례,균경대증처리후전유;간쇠갈1례,경보간치료후호전.무위술기사망환자.112례환자균획득술후수방,중위수방시간위12개월(6~24개월).수방기간,112례환자균건강생존,무일례환자종류복발혹인수술상관병발증사망.결론 수술절제시치료간미상협량성종류적유효수단,환자술후회복량호,수술료효학절.엄격파악수술괄응증,합리우화수술로경,술중채용선택성간혈류조단,정세조작시수술성공적관건.
Objective To evaluate the surgical efficacy of benign tumor of liver in the caudate lobe.Methods The clinical data of 112 patients with benign tumor of liver in the caudate lobe who were admitted to the Eastern Hepatobiliary Surgery Hospital from January 2003 to April 2014 were retrospectively analyzed.The leftsided approach,right-sided approach,bilateral approach,central anterior approach and retrograde caudate lobectomy were selected according to the location and size of the tumor.All the patients were followed up by outpatient examination and telephone interview up to October 2014.Results Of all the 112 patients who received complete resection of tumor,33 patients received caudate lobectomy (22 by bilateral approach,11 by left-sided approach),28 received left hemihepatectomy + caudate lobectomy (by left-sided approach),21 received mesohepatectomy + caudate lobectomy (by central anterior approach),19 received partial right hepatectomy + caudate lobectomy (by right-sided approach),11 received right hemihepatectomy + candate lobectomy (9 by right-sided approach,2 by retrograde caudate lobectomy).During the operation,72 patients received vascular inflow occlusion,29 received vascular inflow occlusion combined with hepatic veins occlusion,6 received total hepatic vascular exclusion and 5 did not receive vascular inflow occlusion.The operation time,mean time of vascular inflow occlusion,mean volume of intraoperative blood loss,cases of blood transfusion,mean volume of blood transfusion and duration of postoperative hospital stay were (192 ± 69)minutes,28 minutes (range,0-94 minutes),590 mL (range,100-12 000 mL),68,600 mL (range,200-10 000mL) and (8.2 ± 2.7) days,respectively.Thirty-one patients had postoperative complications,including 21 with bile leakage,7 with medium and above volume of pleural effusion,2 with postoperative bleeding and 1 with hepatic failure.The complications were cured after symptomatic treatment.No patient died perioperatively.All the 112 patients were followed up for a median time of 12 months (range,6-24 months).All patients were survived well and without tumor recurrence during the follow-up.Conclusions Surgical treatment is an effective method for benign tumor of liver in the caudate lobe,with the good recovery of patients and definitive surgical efficacy.The key factors of surgical treatment include strictly following operative indication,rationally optimizing surgical approach,suitably selecting vascular inflow occlusion and the accurate operation.